Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Archives: Search / 2024 / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013
2019 Archives
Dec 20, 2019 DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that it has closed on a private placement of convertible... |
Dec 3, 2019 DarioHealth Expands Retail Distribution Through Walmart.com Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Walmart is the largest... |
Dario Expands Membership Offering to a New Channel where Retailers are Visited by Millions of Consumers Each Year Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), announced today that its online membership offering will now be available for purchase... |
Nov 15, 2019 - Based on data collected from active users, Dario proves digital interventions can play a key role in management of chronic conditions like diabetes DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting... |
- DarioHealth CEO Joins Digital Health Industry Innovators panel in discussion on the need for clinical evidence DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Dario's CEO, Erez Raphael, will be participating in a panel... |
Action Urgent Care Selects DarioHealth's Blood Glucose Monitoring System™ to Extend Its Existing Digital Health Offering Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of a Dario-powered digital diabetes program with Action Urgent Care. Action Urgent Care... |
Oct 28, 2019 Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported financial and operational results for the third quarter ended September 30, 2019. Q3 2019 Revenues of $1.87... |
Oct 22, 2019 DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, has appointed Dr. Abigail Hirsch to its Advisory Board where she will help guide... |
Oct 17, 2019 Earnings Discussion and Business Update Scheduled for 9:00 am EDT Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its third quarter 2019 results on Monday, October 28, and host a conference call the... |
Sep 23, 2019 - Panel titled "Digital Therapeutics Deliver Evidence-based Results: The Example of DarioHealth" DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth's Chief Executive Officer, will be a... |
Sep 18, 2019 - U.S. patent supports the development and implementation of paired smartphone devices to collect and analyze real-time medical data DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and... |
- Dance Biopharm signs an agreement with DarioHealth to integrate Dance's gentle mist smart inhaler into DarioHealth's platform allowing for automated, real-time treatment data through a mobile application Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced today it has formed a strategic alliance with DarioHealth... |
Aug 28, 2019 Leading global digital therapeutics company DarioHealth Corp. (Nasdaq: DRIO) today announced that DarioHealth's Chief Executive Officer, Erez Raphael, will present to and meet with investors and... |
Aug 15, 2019 - DarioHealth's innovative digital therapeutics solutions will assist the UK National Health Service with managing chronic health conditions, such as diabetes and hypertension DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London ("DH.L") as part of its UK Israel... |
Aug 13, 2019 Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018 Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018 Expense shift from D2C to B2B, resulting in a short-term decline in... |
Aug 12, 2019 Dario Membership users with diabetes achieved a 39% increase of in-range, blood-glucose measurements DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators... |
Aug 7, 2019 Earnings Discussion and Business Update Scheduled for 9:00 am EDT Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its second quarter 2019 results on Tuesday, August 13, and host a conference call the... |
Aug 6, 2019 - Data further underscores clinical evidence of overall health improvement for type 2 Diabetes users of DarioHealth app DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to... |
Jul 30, 2019 New offering enables users to integrate blood pressure readings into the Dario mobile app to gain better understanding and control of overall health. DarioHealth Corp. (Nasdaq: DRIO), ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app... |
Jul 25, 2019 DarioHealth offers USB-C connector configuration between Android smart mobile devices and the Dario Blood Glucose Meter Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today announced that its CE certificate covers a USB-C connector enabled version of the acclaimed Dario™ Blood Glucose... |
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced that on July 5, 2019, it received notification from Nasdaq that the Company has been granted an additional... |
Jun 11, 2019 Digital Therapeutics leader DarioHealth caps off successful week at the ADA with Two Studies Presenting New Real-World Data in the Field of Diabetes DarioHealth Corp. (NASDAQ: DRIO), a leading global Digital Therapeutics (DTx) company with connected devices, mobile software and large data solutions presented two studies reporting new... |
Jun 4, 2019 Functional Medicine Center of Fort Collins, in Fort Collins, CO will incorporate Dario's digital diabetes platform to its health and wellness improvement programs NEW YORK, CAESAREA, Israel and... |
May 29, 2019 Outcomes of several new studies to be released, demonstrating improved life with diabetes. Global digital therapeutics (DTx) innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced its participation at the annual conference of the American Diabetes Association (ADA) in San Francisco on |
May 22, 2019 DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced the pricing of an underwritten public offering of 4,855,341 shares of... |
| 1-25 26-37 |